Evidence map›Paper›PMID 32882315›Full record

ArticleThe Journal of infection2020

The estimation of diagnostic accuracy of tests for COVID-19: A scoping review.

Dierdre B Axell-House, Richa Lavingia, Megan Rafferty, Eva Clark, E Susan Amirian, Elizabeth Y Chiao

Abstract readScoping Review
In one paragraph

Article in The Journal of infection, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Clinical evaluation of the GSD NovaPrime® SARS-CoV-2 RTq-PCR assay.Diagnostic microbiology and infectious disease · 2022
    Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Dierdre B Axell-HouseSection of Infectious Diseases, Department of Internal Medicine, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.
Richa LavingiaBaylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA; School of Social Sciences, Rice University, MS 272, 5620 Greenbriar Dr, Houston, TX 77005, USA; UTHealth School of Public Health, Houston, TX, USA.
Megan RaffertySchool of Social Sciences, Rice University, MS 272, 5620 Greenbriar Dr, Houston, TX 77005, USA; UTHealth School of Public Health, Houston, TX, USA.
Eva ClarkSection of Infectious Diseases, Department of Internal Medicine, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA; Houston HSR&D IQuESt, Michael E. DeBakey VA Medical Center, 2450 Holcombe Blvd, Houston, TX, 77021, USA.
E Susan AmirianSchool of Social Sciences, Rice University, MS 272, 5620 Greenbriar Dr, Houston, TX 77005, USA.
Elizabeth Y ChiaoDepartment of Epidemiology, The University of Texas MD Anderson Cancer Center, 1155 Pressler St., Unit 1340, Houston, TX 77030, USA. Electronic address: eychiao@mdanderson.org.

Funding

The Effectiveness of High Resolution Microendoscopy (HRME) in High Grade Intraepithelial Lesions (HSIL)Diagnosis for People Living with HIVR01CA232890 · NCI · BAYLOR COLLEGE OF MEDICINE · PI ANANDASABAPATHY, SHARMILA, CHIAO, ELIZABETH Y. · 2019 to 2025
$5.2M
The Effectiveness of Screening HIV-Infected Women for Anal Cancer PrecursorsR01CA163103 · NCI · BAYLOR COLLEGE OF MEDICINE · PI CHIAO, ELIZABETH Y. · 2011 to 2015
$2.8M
Texas Medical Center Training Program in Antimicrobial ResistanceT32AI141349 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI GARSIN, DANIELLE A · 2019 to 2023
$1.3M
NCI NIH HHS R01 CA163103NCI NIH HHS R01 CA232890NIAID NIH HHS L30 AI154520NIAID NIH HHS T32 AI141349
6 · The paper itself

Abstract

objectivesTo assess the methodologies used in the estimation of diagnostic accuracy of SARS-CoV-2 real-time reverse transcription polymerase chain reaction (rRT-PCR) and other nucleic acid amplification tests (NAATs) and to evaluate the quality and reliability of the studies employing those methods.

methodsWe conducted a systematic search of English-language articles published December 31, 2019-June 19, 2020. Studies of any design that performed tests on ≥10 patients and reported or inferred correlative statistics were included. Studies were evaluated using elements of the Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) guidelines.

resultsWe conducted a narrative and tabular synthesis of studies organized by their reference standard strategy or comparative agreement method, resulting in six categorizations. Critical study details were frequently unreported, including the mechanism for patient/sample selection and researcher blinding to results, which lead to concern for bias.

conclusionsCurrent studies estimating test performance characteristics have imperfect study design and statistical methods for the estimation of test performance characteristics of SARS-CoV-2 tests. The included studies employ heterogeneous methods and overall have an increased risk of bias. Employing standardized guidelines for study designs and statistical methods will improve the process for developing and validating rRT-PCR and NAAT for the diagnosis of COVID-19.

Indexed as

Data AccuracyAdolescentAdultAgedAged, 80 and overBetacoronavirusChildChild, PreschoolClinical Laboratory TechniquesCoronavirus InfectionsCOVID-19COVID-19 TestingCOVID-19 VaccinesDiagnostic Tests, RoutineFemaleHumansCOVID-19 VaccinesCOVID-19Diagnostic accuracyQUADAS-2SARS-CoV-2SensitivitySpecificity

Identifiers

PMID32882315
PMCPMC7457918

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.